Repligen | RGEN - Market Capitalization


Repligen reported $7.44B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 32.66B 5.2B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
Bio Techne USD 8.18B 987M Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Bruker USD 5.5B 1.66B Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Danaher USD 128.46B 33.24B Mar/2026
Dentsply International USD 2.32B 36M Mar/2026
General Electric Aerospace USD 296.49B 28.42B Mar/2026
Henry Schein USD 8.27B 689M Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Mettler Toledo International USD 25.54B 2.94B Mar/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Pfizer USD 153.81B 12.24B Mar/2026
Repligen USD 6.64B 2.58B Mar/2026
Revvity USD 9.94B 1.03B Mar/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Waters USD 29.87B 7.25B Mar/2026
West Pharmaceutical Services USD 18.07B 1.73B Mar/2026